HER2 + GASTRIC CANCER
Clinical trials for HER2 + GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + GASTRIC CANCER trials appear
Sign up with your email to follow new studies for HER2 + GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Drug attack shows promise against tough stomach cancer
Disease control Recruiting nowThis study tests a combination of three drugs (zanidatamab, pembrolizumab, and chemotherapy) in people with advanced stomach or esophageal cancer that has spread and tests positive for HER2 and PD-L1. The goal is to see if this triple therapy can keep the cancer from growing for …
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New pill takes on hard-to-treat HER2 cancers, including brain tumors
Disease control Recruiting nowThis early-phase trial tests an experimental drug called IAM1363 in people with advanced cancers that have HER2 alterations. The study aims to find a safe dose and see if the drug can shrink tumors, including those that have spread to the brain. About 383 adults whose cancer has …
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated May 18, 2026 12:10 UTC